Jessica M Brown

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Pseudomonas Aeruginosa

Advanced Non Small Cell Lung Cancer

Mesenchymal Stem Cells

Top Venues

Cancer research communications

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rhonda L Bitting, Janet A Tooze, Michael Goodman, Donald C Vile, Jessica M Brown, Christopher Y Thomas, Morgan Neve, Mitra Kooshki, Safoa Addo, Pierre L Triozzi, Purnima Dubey
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma. Cancer research communications 4 (2) (2024)
Rhonda L Bitting, Janet A Tooze, Michael Goodman, Donald C Vile, Jessica M Brown, Christopher Y Thomas, Morgan Neve, Mitra Kooshki, Safoa Addo, Pierre L Triozzi, Purnima Dubey
Low Dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum Refractory Urothelial Carcinoma. Cancer research communications (2024)
Rhonda L Bitting, Janet A Tooze, Michael Goodman, Donald C Vile, Jessica M Brown, Christopher Y Thomas, Morgan Neve, Mitra Kooshki, Safoa Addo, Pierre L Triozzi, Purnima Dubey
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma. Cancer research communications 4 (2) (2024)
Eric L Smith, Kim Harrington, Mette Staehr, Reed Masakayan, Jon Jones, Thomas J Long, Khong Y Ng, Majid Ghoddusi, Terence J Purdon, Xiuyan Wang, Trevor Do, Minh Thu Pham, Jessica M Brown, Carlos Fernandez De Larrea, Eric Olson, Elizabeth Peguero, Pei Wang, Hong Liu, Yiyang Xu, Sarah C Garrett-Thomson, Steven C Almo, Hans-Guido Wendel, Isabelle Riviere, Cheng Liu, Blythe Sather, Renier J Brentjens
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells. Science translational medicine 11 (485) (2020)